Clik here to view.
Clik here to view.
Lombard Medical and MicroPort Scientific Corporation Finalize Strategic...
OXFORDSHIRE, U.K. & SHANGHAI Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair, and MicroPort Scientific Corporation (HK: 0853), a leading...
View ArticleClik here to view.
Ra Medical Systems的Pharos皮肤激光系统已在中国获得核准
加州卡尔斯巴德 (美国商业资讯) — 心血管及皮肤病准分子激光及导管生产商Ra Medical Systems, Inc.的Pharos准分子激光系统已获得中华人民共和国FDA (CFDA)核准，用于治疗银屑病、白癜风和其他皮肤病。 Ra Medical Systems正在中国积极寻找经销商。 Pharos在美国、中东和亚洲部分市场拥有十年以上经过验证的临床成功，已开展数百万例治疗。...
View ArticleClik here to view.
Meiji Seika and Eisai Enter into a Collaboration for the Development and...
MILAN Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS)...
View ArticleClik here to view.
Sosei Subsidiary Heptares to Receive US$12 Million Milestone Payment from...
TOKYO Sosei Group Corporation (“Sosei”; TSE Mothers Index:4565) reported that its subsidiary, Heptares Therapeutics (“Heptares”) has announced that it has achieved an important milestone in its...
View ArticleClik here to view.
Finch Therapeutics and Takeda Announce Global Collaboration to Develop...
OSAKA, Japan & SOMERVILLE, Mass. Finch Therapeutics, a privately held microbiome engineering company, and Takeda Pharmaceutical Company Limited (“Takeda”) (TSE: 4502), today announced a global...
View ArticleClik here to view.
Takeda Completes Enrollment of More Than 20,000 Children and Adolescents in...
OSAKA, Japan Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that it has completed enrollment of 20,100 children and adolescents ages 4 through 16 in its global,...
View ArticleClik here to view.
Certara’s d3 Medicine Partners with the Australian Department of Defence to...
PRINCETON, N.J. Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that its d3...
View ArticleClik here to view.
Acelity Names R. Andrew Eckert President and Chief Executive Officer
SAN ANTONIO Acelity L.P. Inc., a leading global advanced wound care company, today announced that it has named R. Andrew Eckert as President and Chief Executive Officer. Eckert succeeds Joseph...
View ArticleClik here to view.
Simulations Plus Finalizes Distributor Agreement With Korean Company
LANCASTER, Calif. Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling & simulation solutions for the pharmaceutical, biotechnology, and chemicals industries, today announced...
View ArticleClik here to view.
Aurinia Announces Development Plans for Voclosporin in Europe and Japan
VICTORIA, British Columbia Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”), today announced the outcome of discussions with both the European Medicines Agency (EMA)...
View ArticleClik here to view.
U.S. FDA Approves Increased Compassionate Use Patient Cases and Sites for...
VALENCIA, Calif. & PERTH, Australia & LONDON The U.S. Food and Drug Administration has approved a further increase in the number of patients who can be treated in the United States with the...
View ArticleClik here to view.
Chi-Med Presented Pre-clinical Data for Fruquintinib and Sulfatinib at the...
LONDON Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq:HCM) presented pre-clinical data for fruquintinib and sulfatinib at the American Association for Cancer Research (“AACR”) Annual...
View ArticleClik here to view.
PeptiDream Announces Discovery Collaboration Agreement With Janssen
TOKYO PeptiDream Inc., a public Tokyo-based biopharmaceutical company (“PeptiDream”)(TOKYO: 4587) announced today that it has entered into a multi-target discovery and optimization collaboration...
View ArticleClik here to view.
Takeda Enters into Strategic Collaboration with NuBiyota for Microbiome...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502) today announced a strategic collaboration with NuBiyota LLC for the development of Microbial Ecosystem Therapeutic products for...
View ArticleClik here to view.
武田薬品：腸内細菌由来の治療薬の研究開発に関するNuBiyota社との戦略的提携について
大阪 （ビジネスワイヤ） — 当社は、このたび、NuBiyota LLC（所在地：カナダ オンタリオ州ゲルフ、以下「NuBiyota社」）と、アンメットメディカルニーズが高い消化器系疾患を対象に、NuBiyota社が有するMicrobial Ecosystem Therapeuticを活用した腸内細菌由来の治療薬の研究開発に関する戦略的提携を締結しましたのでお知らせします。...
View ArticleClik here to view.
Fresenius Medical Care AG & Co. KGaA发布2016财年 20-F表格
德国巴特洪堡 (美国商业资讯)全球最大的透析产品和服务提供商Fresenius Medical Care AG & Co. KGaA（简称“公司”或“Fresenius Medical...
View ArticleClik here to view.
フレゼニウス メディカル ケアがフォーム20-Fの2016会計年度報告書を公表
独バートホンブルク （ビジネスワイヤ） 透析用製品／サービスを提供する世界最大企業のフレゼニウス メディカル ケア（「当社」または「フレゼニウス メディカル...
View ArticleClik here to view.
Second Sight’s Argus II Retinal Prosthesis Implanted in First Patient in Asia
SYLMAR, Calif. Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to...
View ArticleClik here to view.
武田与NuBiyota开展有关微生物组治疗药物的战略合作
日本大阪 (美国商业资讯) — 武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TOKYO:4502)今天宣布与NuBiyota LLC开展战略合作，共同开发微生物生态系统治疗产品，用于具有高度未获满足的医疗需求的胃肠病(GI)适应证。...
View Article